In April, private-equity firm New Mountain Capital agreed to sell Real Chemistry for $3 billion after owning the fast-growing medical-marketing agency for six years.
The buyer: New Mountain Capital.
The Private-Equity Maneuver Allowing More Investors to Cash Out
Continuation vehicles were once used by ‘zombie funds’ but now usually contain top-performing companies
In April, private-equity firm New Mountain Capital agreed to sell Real Chemistry for $3 billion after owning the fast-growing medical-marketing agency for six years.
The buyer: New Mountain Capital.